美國議員就克羅格(KR.US)收購競爭對手艾伯森(ACI.US)大型合併交易舉行聽證會
格隆匯10月19日丨據市場消息,負責審查反壟斷問題的美國參議員對食品雜貨公司克羅格(KR.US)收購競爭對手艾伯森(ACI.US)的計劃表示"嚴重關切",並表示他們將於下月就這筆250億美元的交易舉行聽證會。克羅格發言人表示,公司期待着聽證會的到來。該公司在一份聲明中表示:“我們歡迎有機會概述這一交易將如何通過擴大新鮮、負擔得起的食品供應,使美國消費者受益。”另外,美國參議員表達了對該協議的擔憂。他們在給聯邦貿易委員會主席信中寫道:“由於食品價格持續上漲,太多的美國家庭正在為食物上桌而掙扎。”“這次合併引發了相當大的反壟斷擔憂。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.